| 1 | 
Executive Summary | 
| 1.1 | 
Main Findings | 
| 1.2 | 
Main Conclusions | 
| 1.3 | 
Bio-Detection Market Forecast 2011-2016 | 
| 1.3.1 | 
Overview | 
| 1.3.2 | 
Systems and Service & Upgrade Markets 2011-2016 | 
| 1.3.3 | 
Systems & Service Market by Modality 2011-2016 | 
| 1.3.4 | 
Systems & Service Market by Technology Generation 2011-2016 | 
| 1.4 | 
Bio-Detection Next Generation Business Opportunities | 
| 1.5 | 
Technologies Outlook | 
| 2 | 
Introduction | 
| 2.1 | 
Scope | 
| 2.2 | 
Methodology | 
| 2.2.1 | 
Research Methods | 
| 2.2.2 | 
Report Structure | 
| 2.2.3 | 
Assumptions | 
| 2.3 | 
Who is This Report For? | 
| 3 | 
Bio-Detection Market Drivers | 
| 4 | 
Bio-Detection Market Inhibitors | 
| 5 | 
Bio-Detection Industry Competitive Analysis | 
| 6 | 
Bio-Detection Industry SWOT Analysis | 
| 7 | 
Bio-detection Market Dynamics | 
| 8 | 
Defending Against Bioterrorism | 
| 8.1 | 
Definition of Bioterrorism | 
| 8.2 | 
The Threat of Bioterrorism | 
| 8.3 | 
How Real Is The Bioterrorism Threat? | 
| 8.4 | 
Bio-Defense Programs | 
| 8.4.1 | 
Strategy | 
| 8.4.2 | 
Project BioWatch | 
| 8.4.3 | 
Project BioSense | 
| 8.4.4 | 
Project BioShield | 
| 8.5 | 
Bio-Detection The Industry | 
| 9 | 
The Obama Administration Bio Terror Mitigation Strategy | 
| 9.1 | 
Biosurveillance Network | 
| 9.2 | 
Bio-Defense Funding | 
| 9.2.1 | 
Overview | 
| 9.2.2 | 
DHHS Bio-Defense Missions and Funding | 
| 9.2.3 | 
DHS Bio-Defense Missions and Funding | 
| 9.2.4 | 
DOD Bio-Defense Missions and Funding | 
| 9.2.5 | 
DOA Bio-Defense Missions and Funding | 
| 9.2.6 | 
EPA Bio-Defense Missions and Funding | 
| 9.3 | 
The Obama Administration Bio-Defense Strategy | 
| 10 | 
Bio-Detection Technologies Overview | 
| 10.1 | 
Bio-Detection Technology Challenges | 
| 10.1.1 | 
Sampling the Environment | 
| 10.2 | 
The Bio-Detection Process | 
| 10.2.1 | 
Bio-Detectors in a Multitude of Ambient Settings | 
| 10.2.2 | 
Bio-Detection Triggering | 
| 10.2.3 | 
Collection of Particles | 
| 10.2.4 | 
Bio-Particle Detectors | 
| 10.2.5 | 
Bio-Agent Identification | 
| 11 | 
Major Bio-Detection Technological Challenges | 
| 11.1 | 
Challenge 1 Detection of Small Particle Concentration | 
| 11.2 | 
Challenge 2 Eliminating Bio Background | 
| 11.3 | 
Challenge 3 Expensive Reagents | 
| 11.4 | 
Challenge 4 Expensive Equipment Maintenance | 
| 11.5 | 
Challenge 5 Adapting Equipment to Changing Environments | 
| 11.6 | 
Challenge 6 Dealing With Emerging Threats | 
| 12 | 
Bio Detection Technologies Review & Outlook 2011-2016 | 
| 12.1 | 
Bio-Detection Core Technologies Comparison | 
| 12.2 | 
Collector/Concentrator Core Technologies | 
| 12.3 | 
Cyclone Collectors | 
| 12.4 | 
Variable Particle-Size Impactor | 
| 12.5 | 
Virtual Impactors | 
| 12.6 | 
Impingers | 
| 12.7 | 
Reagentless Trigger Core Technologies | 
| 12.7.1 | 
Flow Cytometry | 
| 12.7.2 | 
Particle Sizing | 
| 12.7.3 | 
Gas Chromatography | 
| 12.7.4 | 
Trigger Technologies Drivers | 
| 12.7.5 | 
Trigger Technologies Inhibitors | 
| 12.8 | 
DNA Based Diagnostic Core Technologies | 
| 12.8.1 | 
Overview of DNA-Based Detection | 
| 12.8.2 | 
Polymerase Chain Reaction (PCR) | 
| 12.8.3 | 
DNA / RNA Microarrays | 
| 12.8.4 | 
DNA Technology Drivers | 
| 12.8.5 | 
DNA Technology Inhibitors | 
| 12.9 | 
Antibody-Antigen Diagnostic Core Technologies | 
| 12.9.1 | 
Overview of Antibody-Antigen Reaction | 
| 12.9.2 | 
Hand-Held Immuno-Chromatographic Assays (HHA) | 
| 12.9.3 | 
Magnetic Microbead-Base Assays | 
| 12.9.4 | 
Microfluidic Devices “Lab on a Chip” | 
| 12.9.5 | 
Fluorescence Imaging | 
| 12.9.6 | 
Electrochemical-Luminescence (ECL) | 
| 12.9.7 | 
Antibody/Antigen Technology Drivers | 
| 12.9.8 | 
Antibody/Antigen Technology Inhibitors | 
| 12.1 | 
Signal Analysis Algorithms | 
| 12.10.1 | 
Clustering / Classifier Algorithms | 
| 12.10.2 | 
Image Analysis Algorithms | 
| 12.10.3 | 
Decision Algorithms | 
| 12.10.4 | 
Algorithm Drivers | 
| 12.10.5 | 
Algorithm Inhibitors | 
| 12.11 | 
Rapid Microbiological Technologies | 
| 13 | 
Biological Detection Overview by Application | 
| 13.1.1 | 
Application 1 Emergency Responder Hand-Held Detectors | 
| 13.1.2 | 
Application 2 Emergency Responder Mobile Labs | 
| 13.1.3 | 
Application 3 Indoor Standoff Detectors | 
| 13.1.4 | 
Application 4 Outdoor Standoff Detectors | 
| 14 | 
U.S. Bio-Detection Systems Market Outlook 2011-2016 | 
| 14.1 | 
Methodology | 
| 14.2 | 
Bio-Detection Systems Sales 2011-2016 | 
| 14.2.1 | 
Bio-Detection Systems Revenue Sales by Generation Forecast 2011-2016 | 
| 14.2.2 | 
Bio-Detection Systems Sales by Modality 2011-2016 | 
| 14.3 | 
Bio-Detection Systems Quantity Sales 2011-2016 | 
| 14.3.1 | 
Bio-Detection Systems Quantity Sales by Generation 2011-2016 | 
| 14.3.2 | 
Bio-Detection Systems Quantity Sales by Modality 2011-2016 | 
| 14.4 | 
Outdoor Bio-Detection Systems Market 2011-2016 | 
| 14.4.1 | 
Outdoor Standoff Detection Systems Revenue Sales Outlook 2011-2016 | 
| 14.4.2 | 
Outdoor Standoff Detection Systems Quantity Sales Outlook 2011-2016 | 
| 14.5 | 
Indoor Bio-Detection Systems Market 2011-2016 | 
| 14.5.1 | 
Indoor Standoff Systems Detection Sales 2011-2016 | 
| 14.5.2 | 
Indoor Standoff Systems Unit Sales 2011-2016 | 
| 14.6 | 
First Responder Hand-Held Bio-Detection Systems Market 2011-2016 | 
| 14.6.1 | 
First Responder Hand-Held Systems Sales 2011-2016 | 
| 14.6.2 | 
First Responder Hand-Held Systems Quantity Sales 2011-2016 | 
| 14.7 | 
Mobile Bio-Detection Labs Market 2011-2016 | 
| 14.7.1 | 
First Responder Mobile Labs Sales 2011-2016 | 
| 14.7.2 | 
First Responder Mobile Labs Quantity Sales 2011-2016 | 
| 15 | 
Service & Upgrade Business 2011-2016 | 
| 15.1 | 
Bio-Detection Service & Upgrade Business by Modality 2011-2016 | 
| 15.2 | 
Bio-Detection Service Business by Technology Generation 2011-2016 | 
| 16 | 
Business Opportunities in Bio-Detection 2011-2016 | 
| 16.1 | 
Historical Perspective | 
| 16.1.1 | 
A Market Waiting for Transition | 
| 16.1.2 | 
The Current and Future HLS Bio-Defense Strategy for Detection | 
| 16.1.3 | 
Factors Affecting Biological Detectors Deployment and Technologies 2011-2016 | 
| 16.1.4 | 
Biological Detection Technology Timeline | 
| 16.2 | 
Next Generation HLS Bio-Detection Systems Business Opportunities | 
| 16.2.1 | 
Overview | 
| 16.2.2 | 
Business Opportunity 1 Emerging Threats | 
| 16.2.3 | 
Business Opportunity 2 Human Sentinel Surveillance System | 
| 16.2.4 | 
Business Opportunity 3 Animal Sentinel Surveillance System | 
| 16.2.5 | 
Business Opportunity 4 Biological IC3 Biological Threat Assessment Intelligence Command, Control, and Communication Infrastructure | 
| 16.2.6 | 
Business Opportunity 5 Reducing False Alarms Lesser False Positives and False Negatives | 
| 16.2.7 | 
Business Opportunity 6 Reducing Cost Minimizing Use of Non-Reusable Reagents | 
| 16.3 | 
Outdoor Standoff Biological Detectors | 
| 16.3.1 | 
Business Opportunity 7 Bioagent Autonomous Networked Detectors (BAND) | 
| 16.3.2 | 
Business Opportunity 8 Rapid Automated Biological Identification System (RABIS) | 
| 16.3.3 | 
Business Opportunity 9 First Responder Portable Hand-Held Detector | 
| 16.3.4 | 
Business Opportunity 10 First Responder Mobile Biological Detection Station | 
| 16.3.5 | 
Business Opportunity 11 Regional Automatic Detector Outdoor Standoff Detectors | 
| 16.3.6 | 
Business Opportunity 12 Networked Automatic Detector Indoor Standoff Detectors | 
| 16.3.7 | 
Business Opportunity 13 External Spread of Bioagent Detection | 
| 16.3.8 | 
Business Opportunity 14 Internal Spread of Bioagent | 
| 16.4 | 
Other Bio-Detection Technologies Business Opportunities | 
| 16.4.1 | 
Business Opportunity 15 “Lab on a Chip” Miniature Detection Devices | 
| 16.4.2 | 
Business Opportunity 16 Reagentless Specific Detection Assays | 
| 16.4.3 | 
Business Opportunity 17 Laser Induced Breakdown Spectroscopy (LIBS) | 
| 16.4.4 | 
Business Opportunity 18 Raman Spectroscopy-based Reagentless Detection | 
| 16.5 | 
Future Technologies and Systems | 
| 17 | 
Bio-Detection Personnel Considerations | 
| 17.1 | 
Background Personnel | 
| 17.2 | 
Personnel Training | 
| 18 | 
Vendors | 
| 18.1 | 
20/20 GeneSystems Inc. | 
| 18.2 | 
Advnt Biotechnologies | 
| 18.3 | 
Agilent Technologies | 
| 18.4 | 
Alexeter Technologies | 
| 18.5 | 
ANP Technologies, Inc. | 
| 18.6 | 
BAS – Biological Alarm Systems Ltd. (Israel) | 
| 18.7 | 
BD Biosciences Immunocytometry Systems | 
| 18.8 | 
Bertin Technologies | 
| 18.9 | 
BioDefense Corporation | 
| 18.1 | 
BioDETECT AS | 
| 18.11 | 
BioSentinel Pharmaceuticals LLC | 
| 18.12 | 
3M Microbiology (Biotrace International, Ltd.) | 
| 18.13 | 
BioTraces, Inc. | 
| 18.14 | 
BioVeris Corporation | 
| 18.15 | 
Biral | 
| 18.16 | 
Cepheid | 
| 18.17 | 
Commonwealth Biotechnologies, Inc. | 
| 18.18 | 
Dycor Technologies Ltd. | 
| 18.19 | 
Environics Oy | 
| 18.2 | 
Evogen, Inc. | 
| 18.21 | 
General Dynamics Canada | 
| 18.22 | 
GenPrime, Inc. | 
| 18.23 | 
Groton Biosystems | 
| 18.24 | 
Haztech Systems, Inc. | 
| 18.25 | 
Idaho Technology, Inc. | 
| 18.26 | 
JMAR Technologies, Inc. | 
| 18.27 | 
New Horizons Diagnostics | 
| 18.28 | 
Proengin | 
| 18.29 | 
QTL Biodetection | 
| 18.3 | 
Research International | 
| 18.31 | 
Response Biomedical | 
| 18.32 | 
Roche Applied Science | 
| 18.33 | 
Smiths Detection | 
| 18.34 | 
Tetracore, Inc. | 
| 19 | 
Prices of Bio-Detection Equipment | 
| 20 | 
Appendix A: The Threat of Bioweapons | 
| 20.1 | 
Use of Bioweapons Historical Perspective | 
| 20.2 | 
Biological Terror Bacterial Agents | 
| 20.2.1 | 
Anthrax | 
| 20.2.2 | 
Cholera | 
| 20.2.3 | 
Plague | 
| 20.2.4 | 
Tularemia | 
| 20.3 | 
Biological Terror Viral Agents | 
| 20.3.1 | 
Smallpox | 
| 20.3.2 | 
Hemorrhagic Fever Viruses | 
| 20.3.3 | 
Venezuelan Equine Encephalitis | 
| 20.4 | 
Biological Terror Rickettsiae Agents | 
| 20.4.1 | 
Q Fever | 
| 20.4.2 | 
Typhus | 
| 20.5 | 
Biological Terror Toxins | 
| 20.5.1 | 
Botulinum Toxin | 
| 20.5.2 | 
Ricin | 
| 20.5.3 | 
Saxitoxin | 
| 20.5.4  | 
Staphylococcal Enterotoxin B (SEB) | 
| 21 | 
Appendix B: Legal Issues | 
| 21.1 | 
International / European Legislation / Agreements | 
| 21.1.1 | 
The Biological and Toxin Weapons Convention (BTWC) 1972 | 
| 21.2 | 
U.S. Bioterrorism Legislation |